{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "New Concern About Testosterone and Heart Risks", "kicker": "Well", "print_headline": "Study Adds to Concerns About Cardiac Risks for Older Men Taking Testosterone"}, "abstract": "A large new study found that prescription testosterone raised the risk of heart attacks, prompting some experts on Wednesday to call for more extensive warning labels on the drugs.", "print_page": null, "word_count": "848", "_id": "52e995e07988106e8f5ec598", "snippet": "A large new study found that prescription testosterone raised the risk of heart attacks, prompting some experts on Wednesday to call for more extensive warning labels on the drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2014/01/29/study-adds-to-concern-about-cardiac-risks-for-older-men-taking-testosterone/", "multimedia": [{"subtype": "wide", "url": "images/2013/06/03/health/well_men/well_men-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2013/06/03/health/well_men/well_men-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2013/06/03/health/well_men/well_men-articleLarge.jpg", "height": 421, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2013/06/03/health/well_men/well_men-articleLarge.jpg", "xlargeheight": "421"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2013/06/03/health/well_men/well_men-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/06/03/health/well_men/well_men-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Testosterone", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Heart", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "PLoS One (Journal)", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Labeling and Labels", "is_major": "Y", "rank": "5", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Anahad", "lastname": "O'CONNOR"}], "original": "By ANAHAD O'CONNOR"}, "document_type": "blogpost", "pub_date": "2014-01-29T18:58:14Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The drug Xtandi, already on the market for post-chemotherapy use, could open a new front in its competition with Johnson & Johnson&#8217;s Zytiga.", "headline": {"main": "Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy", "print_headline": "Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy"}, "abstract": "Study shows that prostate cancer drug Xtandi, approved for use after chemotherapy, is also effective before chemotherapy in men with advanced cases of the disease; findings could open up a new front for the drug, developed by Medivation and Astellas Pharma, as it competes with Johnson & Johnson's Zytiga.", "print_page": "3", "word_count": "487", "_id": "52e864a679881029dda8ead6", "snippet": "The drug Xtandi, already on the market for post-chemotherapy use, could open a new front in its competition with Johnson & Johnson&#8217;s Zytiga.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/01/29/health/drug-shows-promise-in-advanced-prostate-cancer-when-used-before-chemotherapy.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Astellas Pharma", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Prostate Cancer", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Johnson & Johnson", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Medivation Inc", "is_major": "N", "rank": "3", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-01-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Debt can pile up quickly for couples trying in-vitro fertilization and other assisted reproductive technologies.", "headline": {"main": "Meeting the Cost of Conceiving", "kicker": "Your Money Adviser", "content_kicker": "Your Money"}, "abstract": null, "print_page": "", "word_count": "1065", "_id": "52e84e1279881029dda8ea98", "snippet": "Debt can pile up quickly for couples trying in-vitro fertilization and other assisted reproductive technologies.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/01/29/your-money/meeting-the-cost-of-conceiving.html", "multimedia": [{"width": 190, "url": "images/2014/01/29/your-money/29adviser/29adviser-thumbWide.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2014/01/29/your-money/29adviser/29adviser-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2014/01/29/your-money/29adviser/29adviser-articleLarge.jpg", "height": 399, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2014/01/29/your-money/29adviser/29adviser-articleLarge.jpg", "xlargeheight": "399"}, "type": "image"}, {"width": 75, "url": "images/2014/01/29/your-money/29adviser/29adviser-thumbStandard.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/01/29/your-money/29adviser/29adviser-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"rank": "1", "is_major": "N", "value": "In Vitro Fertilization", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Personal Finances", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Ann", "rank": 1, "lastname": "CARRNS"}], "original": "By ANN CARRNS"}, "document_type": "article", "pub_date": "2014-01-29T00:00:00Z", "section_name": "Your Money"}], "meta": {"hits": 3, "offset": 0, "time": 358}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}